Halitosis Treatment Market Competitive Landscape, Top Company Profile and Regional Statistics 2027

Your avatar
Your avatar

Some of these elite players include Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S).

 Halitosis treatment market information: by type (pathologic halitosis, others), by indication (respiratory, liver, kidney, gastrointestinal, systemic, others), by diagnostic tests (halimeter, gas chromatography, BANA Test, β-galactosidase activity assay, others), by drug treatment (antacids, antiseptics, ranitidine, others) - forecast till 2027

 Get a FREE Sample with Complete TOC @

Halitosis is where an unpleasant odor is present in the mouth because of several periodontal and chronic diseases. Some of the most common causes are the lack of oral hygiene and awareness about the diagnosis of this disease. The Market Research Future report on halitosis treatment market has projected that it will reach a valuation of USD 22,153.4 billion by the end of 2023. Some factors primarily contributing to the growth of the halitosis market include the availability of a vast array of dental healthcare products, rising prevalence of periodontal diseases, and growing senior population.

The MRFR report states that the global Halitosis Treatment Market will register a phenomenal CAGR of 18.58% during the assessment period. Some other factors contributing to the positive ascension of the market include the initiatives by government and the emergence of strong technological support. Further, surgical, pathological, and endodontic factors like a non-vital tooth with fistula which drains in the mouth and exposed tooth pulps are upscaling the growth graph of the halitosis treatment market. Additionally, the manufacturers are focused on the approval and development of new products along with collaborations with industry players, pushing the market.

Market Segmentation

The global halitosis market has been analyzed for various segments on the basis of type of halitosis, indication, drug treatment, and diagnostic test. Based on type of halitosis, the segments included are pathological halitosis and physiological halitosis. The pathological halitosis segment is further segmented into oral pathological halitosis and extraoral pathological halitosis.

Based on indication, the global halitosis treatment is segmented into respiratory, kidney, liver, systemic, and gastrointestinal. The respiratory segment is further sub-segmented into gall bladder diseases and liver failure. The kidney segment is studied for the sub-segment of uremia. The gastrointestinal segment is further segmented into stomach cancer, malabsorption, esophageal reflux, and pharyngitis. The systemic segment includes the sub-segment of diabetes.

Based on diagnostic test, the halitosis treatment market is segmented into gas chromatography, halimeter, BANA test, and β-galactosidase activity assay. On the basis of drug treatment, the global halitosis treatment market has been studied for the segments of antiseptic, antacids, cetylpyridinium, cimetidine, and ranitidine.

Regional Segmentation

The global halitosis treatment market has been studied for the regional segments of the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa. The Americas are likely to account for the largest market share for halitosis treatment. Such market domination is attributable to the extensive usage of oral care products. In 2013, the U.S. garnered 810 million for halitosis treatments.

Europe is showcased to hold the second largest share for halitosis treatment, thanks to increasing awareness regarding halitosis and higher availability of treatment products. Additionally, rising demand for new oral care products is projected to fuel market growth.  Asia Pacific is estimated to burgeon at an alarming rate owing to an increasing prevalence of chronic diseases such as diabetes, kidney or liver failure, respiratory diseases with a proliferation of population. The rising population of senior citizens who suffer from such chronic diseases is also having a substantial effect on the growth of the halitosis treatment market. In contrast, the Middle East & Africa is estimated to garner moderate growth during the review period due to a lack of awareness regarding oral health, and poor economic conditions.


Get More Information on Halitosis Treatment Market Research Report – Global Forecast till 2023 @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.

Cheer up, leave your comment
If you liked this post, you may also be interested in...
© 2021, Mamby Investments
Information Work with us Contact FAQs Creators Terms and Conditions